Treatment of non-small cell lung cancer patients with proton beam-based stereotactic body radiotherapy: dosimetric comparison with photon plans highlights importance of range uncertainty.
about
Particle therapy for non-small cell lung tumors: where do we stand? A systematic review of the literatureParticle beam radiation therapy using carbon ions and protons for oligometastatic lung tumors.Impact of different beam directions on intensity-modulated radiation therapy dose delivered to functioning lung tissue identified using single-photon emission computed tomography.Feasibility of proton transmission-beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy for lung tumors: a dosimetric and feasibility studyProton SBRT for medically inoperable stage I NSCLC.Re-irradiation of recurrent head and neck carcinomas: comparison of robust intensity modulated proton therapy treatment plans with helical tomotherapyThe use of proton-beam therapy in the treatment of non-small-cell lung cancer.Proton-based stereotactic ablative radiotherapy in early-stage non-small-cell lung cancer.Proton Beam Therapy for Non-Small Cell Lung Cancer: Current Clinical Evidence and Future Directions.Proton beam therapy in Japan: current and future status.3D delivered dose assessment using a 4DCT-based motion model.Proton beam therapy in non-small cell lung cancer: state of the art.Comparison of dose-volume histograms between proton beam and X-ray conformal radiotherapy for locally advanced non-small-cell lung cancer.Dosimetric impact of number of treatment fields in uniform scanning proton therapy planning of lung cancer.Changes in the radiological depth correlate with dosimetric deterioration in particle therapy for stage I NSCLC patients under high frequency jet ventilation.Image guidance in proton therapy for lung cancer.Dosimetric feasibility of 4DCT-ventilation imaging guided proton therapy for locally advanced non-small-cell lung cancer.
P2860
Q27023426-1E35B79F-B288-4C3F-8E1C-E228B3897C3FQ34123571-87D3C371-635A-41A9-9B11-01C6CD4AFC7FQ35165551-CBD792FF-7E79-440D-9DC2-9CBFC463B976Q35179720-74FA1D77-3C21-48F2-B719-3B2F445F495FQ35965653-A4B139CB-78C7-4B32-8917-275400AB71BCQ36828148-5DB2899B-2348-4529-A23E-3F35C7581150Q38088273-1E9CD98B-D0D3-4885-9A54-12D0CF7BE72CQ38241214-3143AF86-EF1A-42BE-BBA6-187BF3831A68Q38543109-B540EA86-84B4-4E18-86B0-78EE88EF4C0FQ38830371-9DC9E79C-6957-457D-944C-C3A601BA9D61Q40292839-D241F493-8ACF-4F8D-8997-224BF7383461Q41546002-C36E79A8-FCC9-4016-88C2-17E4E4BF444EQ42584254-8DBB0F3A-5170-473D-B3A0-F7B56B2B5139Q43057931-5F3725F3-E032-4B28-8F68-6225DB935328Q53400054-FD5DCFD8-E1BF-48F5-B236-03F9CB5793D1Q55043632-ACD32C50-E684-4EF3-B4CD-A87FE70074F6Q55373951-B9F378F2-B907-44CD-98A7-E5D4D1CD9A42
P2860
Treatment of non-small cell lung cancer patients with proton beam-based stereotactic body radiotherapy: dosimetric comparison with photon plans highlights importance of range uncertainty.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Treatment of non-small cell lu ...... portance of range uncertainty.
@en
Treatment of non-small cell lu ...... portance of range uncertainty.
@nl
type
label
Treatment of non-small cell lu ...... portance of range uncertainty.
@en
Treatment of non-small cell lu ...... portance of range uncertainty.
@nl
prefLabel
Treatment of non-small cell lu ...... portance of range uncertainty.
@en
Treatment of non-small cell lu ...... portance of range uncertainty.
@nl
P2093
P1476
Treatment of non-small cell lu ...... portance of range uncertainty.
@en
P2093
Hamid Reza Panahandeh
Henning Willers
Judith Adams
P304
P356
10.1016/J.IJROBP.2011.05.062
P407
P577
2011-10-08T00:00:00Z